No Data
No Data
Investors Holding Back On Privia Health Group, Inc. (NASDAQ:PRVA)
Earnings Preview: PRVA to Report Financial Results Pre-market on November 07
Barclays Maintains Privia Health(PRVA.US) With Hold Rating, Maintains Target Price $19
Privia Health Group Reports FY Results
Privia Health Group Shares Are Trading Higher After the Company Announced Its Accountable Care Organizations Achieved Savings of $176.6 Million Through the Medicare Shared Savings Program for the 2023 Performance Year.
Evercore Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $22